Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Duda

Showing results (51-60 of 222) with videos related to

Pageof 23
Sort By:
Neuroscience Bulletin|August 24, 2017
Olfactory Dysfunction as an Early Biomarker in Parkinson's DiseaseMichelle E Fullard, James F Morley, John E Duda
Acta Neuropathologica|April 17, 2008
Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusionsElisa A Waxman, John E Duda, Benoit I Giasson
AJNR. American Journal of Neuroradiology|January 1, 1980
CT of subacute sclerosing panencephalitisE E Duda, P R Huttenlocher, N J Patronas
Radiology|December 1, 1983
Cervical and lumbar metrizamide myelography. Split-dose techniqueJ P Alenghat, H S Kim, E E Duda
Journal of Neuroscience Research|July 6, 2000
Neuropathology of synuclein aggregatesJ E Duda, V M Lee, J Q Trojanowski
AJR. American Journal of Roentgenology|January 1, 1979
Radiographic presentation of spinal abscess in the subdural spaceN J Patronas, W J Marx, E E Duda
Developmental Medicine and Child Neurology|February 1, 1987
Factors affecting cognitive functioning of hemiplegic childrenS C Levine, P Huttenlocher, M T Banich, et al.
Surgical Neurology|March 1, 1976
Intracranial pressure gradients in a patient with a thalamic tumorH A Crockard, K Hanlon, E Ganz, et al.
Parkinsonism & Related Disorders|October 18, 2019
Comparing self-reported and objective monitoring of physical activity in Parkinson diseaseSneha Mantri, Stephanie Wood, John E Duda, et al.
Orvosi Hetilap|June 13, 1993
[Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use]Z Bebök, G Szekeres, G Horváth, et al.
Pageof 23

Showing results (51-60 of 222) with videos related to

Sort By:
Pageof 23
Neuroscience Bulletin|August 24, 2017
Olfactory Dysfunction as an Early Biomarker in Parkinson's DiseaseMichelle E Fullard, James F Morley, John E Duda
Acta Neuropathologica|April 17, 2008
Characterization of antibodies that selectively detect alpha-synuclein in pathological inclusionsElisa A Waxman, John E Duda, Benoit I Giasson
AJNR. American Journal of Neuroradiology|January 1, 1980
CT of subacute sclerosing panencephalitisE E Duda, P R Huttenlocher, N J Patronas
Radiology|December 1, 1983
Cervical and lumbar metrizamide myelography. Split-dose techniqueJ P Alenghat, H S Kim, E E Duda
Journal of Neuroscience Research|July 6, 2000
Neuropathology of synuclein aggregatesJ E Duda, V M Lee, J Q Trojanowski
AJR. American Journal of Roentgenology|January 1, 1979
Radiographic presentation of spinal abscess in the subdural spaceN J Patronas, W J Marx, E E Duda
Developmental Medicine and Child Neurology|February 1, 1987
Factors affecting cognitive functioning of hemiplegic childrenS C Levine, P Huttenlocher, M T Banich, et al.
Surgical Neurology|March 1, 1976
Intracranial pressure gradients in a patient with a thalamic tumorH A Crockard, K Hanlon, E Ganz, et al.
Parkinsonism & Related Disorders|October 18, 2019
Comparing self-reported and objective monitoring of physical activity in Parkinson diseaseSneha Mantri, Stephanie Wood, John E Duda, et al.
Orvosi Hetilap|June 13, 1993
[Creation of monoclonal antibodies against tumor necrosis factor-alpha (TNF-alpha) and transforming growth factor alpha (TFG-alpha), their definition and possible use]Z Bebök, G Szekeres, G Horváth, et al.
Pageof 23